Diabetes Mellitus, Type 2 Clinical Trials in Seoul
7 recruitingSeoul, South Korea
Showing 1–7 of 7 trials
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1152 locationsNCT07064473
Recruiting
Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia
Diabetes Mellitus, Type 2
Daewoong Pharmaceutical Co. LTD.12,000 enrolled1 locationNCT06647888
Recruiting
SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study
Diabetes Mellitus, Type 2Myocardial Infarction
Kiyuk Chang1,000 enrolled1 locationNCT05770687
Recruiting
Phase 4
A Prospective Trial of Enavogliflozin to Evaluate Cardio-renal Outcome in Type 2 Diabetes Mellitus Patients
Cardiovascular DiseasesDiabetes Mellitus, Type 2Kidney Diseases
Yonsei University2,862 enrolled1 locationNCT06642623
Recruiting
Phase 1
To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic Function
Diabetes Mellitus, Type 2
Daewoong Pharmaceutical Co. LTD.24 enrolled1 locationNCT05747664
Recruiting
Phase 1
A Study to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Characteristics and Food Effect of HGR4113 in Healthy Subjects
Diabetes Mellitus, Type 2
Glaceum40 enrolled1 locationNCT05642377
Recruiting
Not Applicable
Patient-Driven Lifestyle Modification Using FreeStyle Libre in Type 2 Diabetes Patients
Diabetes Mellitus, Type 2Lifestyle Risk Reduction
Seoul National University Hospital126 enrolled1 locationNCT04932928